301 related articles for article (PubMed ID: 17764571)
1. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.
Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE
BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study.
Bajaj NP; Gontu V; Birchall J; Patterson J; Grosset DG; Lees AJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1223-8. PubMed ID: 20547625
[TBL] [Abstract][Full Text] [Related]
6. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
Vaamonde J; Ibáñez R; García AM; Poblete V
Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
[TBL] [Abstract][Full Text] [Related]
7. IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.
Derlin T; Afzal W; Wilke F; Apostolova I; Klutmann S; Meyer PT; Buhmann C; Hesse S; Buchert R
Nuklearmedizin; 2010; 49(4):139-47. PubMed ID: 20502846
[TBL] [Abstract][Full Text] [Related]
8. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.
Poewe W; Scherfler C
Mov Disord; 2003 Oct; 18 Suppl 7():S16-21. PubMed ID: 14531041
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
[TBL] [Abstract][Full Text] [Related]
10. Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study.
Mo SJ; Linder J; Forsgren L; Larsson A; Johansson L; Riklund K
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2154-64. PubMed ID: 20593284
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.
Buchert R; Buhmann C; Apostolova I; Meyer PT; Gallinat J
Dtsch Arztebl Int; 2019 Nov; 116(44):747-754. PubMed ID: 31774054
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
Ba F; Martin WR
Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
[TBL] [Abstract][Full Text] [Related]
15. The role of molecular imaging in the differential diagnosis of parkinsonism.
Booij J; Teune LK; Verberne HJ
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):17-26. PubMed ID: 22460157
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
Bajaj N; Hauser RA; Grachev ID
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
[TBL] [Abstract][Full Text] [Related]
17. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
18. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
Meyer PT; Amtage F; Hellwig S
Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
[TBL] [Abstract][Full Text] [Related]
20. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
